Solutions

Three ways to buy a briefing. One retainer if this becomes how you work.

Compared with a €100–150k opportunity assessment, this is not a cheaper version of the same project. It is a different object: a working indication model, human-signed, built to be re-opened when a readout moves.

Snapshot

€12,000

per indication · 5 business days

The exec view Corp Dev actually reads. Enough to kill or keep a conversation.

Executive snapshot (thesis, so-what, residual unmet need)
Epidemiology funnel for one geography set (US / EU5 / JP)
Treatment algorithm with share, efficacy, safety
Pipeline cut by phase, modality, pathway, route
List pricing on marketed products
PPT + Excel extract

No KOL / CoE / voice layer. No asset valuation.

Request Snapshot

Brief

€28,000

per indication · 10 business days

The product we expect most Search & Eval teams to buy. A working model, not a PDF.

Everything in Snapshot
Interactive epidemiology (mutation, stage, geography)
KOL map + centers of excellence / clinic networks
Patient and clinician voice themes
One asset deep-dive (PoS, time-to-market, peak build)
Quarterly data refresh for 12 months

Additional assets billed as add-ons.

Request Brief

Mandate

€48,000

per indication · 15 business days

When the asset is live in a process and the IC needs a number, not a narrative.

Everything in Brief
Up to four asset deep-dives with scenario trees
Custom addressable-market build the team can edit
Competitor war-gaming and deal implications
Two working sessions with the Aperture partners
Priority refresh if a readout or label moves

Does not replace full commercial DD on a live bid.

Request Mandate

Aperture Desk

€9,500/ month

A living library. New snapshots on request, existing briefs kept current.

Access to the indication library
Two Snapshot-level refreshes per quarter
On-demand questions on live briefs
Alerting when a late-stage readout or label changes